Fetal RhD genotyping by maternal serum analysis: A two-year experience


      The purpose of this study was to determine the accuracy of the none-invasive prenatal determination of polymerase chain reaction (PCR)-based fetal RhD genotyping.

      Study design

      A prospective case series was undertaken on all RhD-negative pregnant women presenting for genetic counseling in our prenatal diagnosis center from January 2001 until December 2002. Results were compared with serologic RhD typing of the newborns.


      Among the 285 pregnant women who participated in the study, fetal RhD status could be determined for 283 patients. In 2 cases, the RhD-negative phenotype of the mother was not the result of a complete RHD gene deletion, and therefore, the status of the fetus could not be determined. Neither false-negative nor false-positive results were observed.


      The present report demonstrates that a reliable fetal RHD genotype determination can be achieved with 100% accuracy. It is therefore possible to consider that such an assay could be systematically proposed to all RhD-negative pregnant women in order to more effectively utilize RhD prophylaxis.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Moise Jr., K.J.
        Management of rhesus alloimmunization in pregnancy.
        Obstet Gynecol. 2002; 100: 600-611
        • American College of Obstetrics and Gynecology
        ACOG practice bulletin. Prevention of RhD alloimmunization. Clinical management guidelines for obstetrician-gynecologists.
        Int J Gynaecol Obstet. 1999; 66: 63-70
        • Amicucci P.
        • Gennarelli M.
        • Novelli G.
        • Dallapiccola B.
        Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma.
        Clin Chem. 2000; 46: 301-302
        • Saito H.
        • Sekizawa A.
        • Morimoto T.
        • Suzuki M.
        • Yanaihara T.
        Prenatal DNA diagnosis of a single-gene disorder from maternal plasma.
        Lancet. 2000; 356: 1170
        • Costa J.M.
        • Benachi A.
        • Gautier E.
        • Jouannic J.M.
        • Ernault P.
        • Dumez Y.
        First-trimester fetal sex determination in maternal serum using real-time PCR.
        Prenat Diagn. 2001; 21: 1070-1074
        • Honda H.
        • Miharu N.
        • Ohashi Y.
        • Samura O.
        • Kinutani M.
        • Hara T.
        • et al.
        Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum.
        Hum Genet. 2002; 110: 75-79
        • Costa J.M.
        • Benachi A.
        • Gautier E.
        New strategy for prenatal diagnosis of X-linked disorders.
        N Engl J Med. 2002; 346: 1502
        • Rijnders R.J.
        • van der Schoot C.E.
        • Bossers B.
        • de Vroede M.A.
        • Christiaens G.C.
        Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia.
        Obstet Gynecol. 2001; 98: 374-378
        • Lo Y.M.
        • Hjelm N.M.
        • Fidler C.
        • Sargent I.L.
        • Murphy M.F.
        • Chamberlain P.
        • et al.
        Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
        N Engl J Med. 1998; 339: 1734-1738
        • Faas B.H.
        • Beuling E.A.
        • Christiaens G.C.
        • von dem Borne A.E.
        • van der Schoot C.E.
        Detection of fetal RHD-specific sequences in maternal plasma.
        Lancet. 1998; 352: 1196
        • Bischoff F.Z.
        • Nguyen D.D.
        • Marquez-Do D.
        • Moise Jr., K.J.
        • Simpson J.L.
        • Elias S.
        Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR.
        J Soc Gynecol Investig. 1999; 6: 64-69
        • Zhong X.Y.
        • Holzgreve W.
        • Hahn S.
        Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction.
        BJOG. 2000; 107: 766-769
        • Costa J.M.
        • Giovangrandi Y.
        • Ernault P.
        • Lohmann L.
        • Nataf V.
        • El Halali N.
        • et al.
        Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
        Br J Haematol. 2002; 119: 255-260
        • Finning K.M.
        • Martin P.G.
        • Soothill P.W.
        • Avent N.D.
        Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.
        Transfusion. 2002; 42: 1079-1085
        • Rouillac-Le Sciellour C.
        • Puillandre P.
        • Gillot R.
        • Baulard C.
        • Métral S.
        • Le Van Kim C.
        • et al.
        Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
        Mol Diagn. 2004; 8: 23-31
        • Van Der Schoot C.E.
        • Tax G.H.
        • Rijnders R.J.
        • De Haas M.
        • Christiaens G.C.
        Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
        Transfus Med Rev. 2003; 17: 31-44
        • Power J.P.
        • Davidson F.
        • O'Riordan J.
        • Simmonds P.
        • Yap P.L.
        • Lawlor P.
        Hepatitis C infection from anti-D immunoglobulin.
        Lancet. 1995; 346: 372-373
        • Johnson K.L.
        • Dukes K.A.
        • Vidaver J.
        • Leshane E.S.
        • Ramirez I.
        • Weber W.D.
        • et al.
        Interlaboratory comparison of fetal male DNA detection from common maternal plasma by real-time PCR.
        Clin Chem. 2004; 50: 516-521